Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Inspecs Group plc

Healthcare GB SPEC

84.5GBX
0.00(0%)

Last update at 2026-06-04T09:26:00Z

Day Range

84.5087.00
LowHigh

52 Week Range

38.0087.00
LowHigh

Fundamentals

  • Previous Close 84.50
  • Market Cap84.39M
  • Volume566
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA9.74M
  • Revenue TTM195.28M
  • Revenue Per Share TTM1.92
  • Gross Profit TTM 101.07M
  • Diluted EPS TTM-0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -1.02300M 0.21M -9.48100M -9.13200M -11.16300M
Minority interest - - - - -
Net income -4.60800M -0.99700M -7.81600M -5.43500M -8.91300M
Selling general administrative 94.30M 94.64M 115.97M 106.44M 22.68M
Selling and marketing expenses 5.74M 6.02M 7.78M 7.79M 0.79M
Gross profit 103.45M 103.55M 122.29M 115.77M 20.52M
Reconciled depreciation 12.82M 13.04M 16.87M 18.45M 3.91M
Ebit 2.93M 4.23M -4.81200M -4.24600M -2.94000M
Ebitda 15.75M 17.27M 12.06M 14.20M -0.12300M
Depreciation and amortization 12.82M 13.04M 16.87M 18.45M 2.82M
Non operating income net other - - - - -
Operating income 3.41M 2.89M -4.81200M -4.24600M -2.94000M
Other operating expenses 194.84M 200.40M 250.04M 244.93M 50.35M
Interest expense 3.96M 4.02M 2.85M 2.30M 0.63M
Tax provision 3.58M 1.21M -1.66500M -3.69700M -2.25000M
Interest income 0.20M 0.24M 0.13M 0.12M 0.04M
Net interest income -4.03600M -3.91500M -3.69500M -2.65700M -1.84400M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 3.58M 1.21M -1.66500M -3.69700M -2.25000M
Total revenue 198.26M 203.29M 248.58M 246.47M 47.41M
Total operating expenses 100.04M 100.66M 123.75M 114.23M 23.46M
Cost of revenue 94.81M 99.75M 126.29M 130.70M 26.89M
Total other income expense net -4.43600M -2.67300M -4.66900M -4.88600M -8.22300M
Discontinued operations - - - - -
Net income from continuing ops -4.60800M -0.99700M -7.81600M -5.43500M -8.91300M
Net income applicable to common shares - - -7.81600M -5.43500M -8.91300M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 220.25M 221.91M 292.68M 326.36M 310.45M
Intangible assets 23.41M 29.81M 43.76M 54.45M 56.30M
Earning assets - - - - -
Other current assets 3.26M 27.58M 1.01M 45.70M 37.20M
Total liab 121.56M 118.39M 162.59M 181.13M 164.64M
Total stockholder equity 98.69M 103.52M 130.09M 145.22M 145.82M
Deferred long term liab - - - - -
Other current liab 25.20M 25.04M 17.62M 11.10M 12.82M
Common stock 1.02M 1.02M 1.39M 1.39M 1.38M
Capital stock 1.02M 1.02M 1.39M 1.39M 1.38M
Retained earnings -5.59000M -1.00500M 0.22M 9.43M 14.43M
Other liab - - 13.19M 29.02M 24.69M
Good will 55.74M 55.58M 67.23M 81.36M 69.09M
Other assets - - 8.48M 12.54M 12.99M
Cash 23.96M 20.07M 26.80M 29.76M 32.67M
Cash and equivalents - - - - -
Total current liabilities 75.09M 65.86M 129.38M 82.92M 69.55M
Current deferred revenue - 17.19M - 2.78M 4.36M
Net debt 38.51M 42.05M 57.62M 55.16M 47.19M
Short term debt 17.96M 13.89M 64.40M 15.72M 9.47M
Short long term debt 11.57M 10.54M 60.01M 2.43M 6.50M
Short long term debt total 62.47M 62.12M 84.42M 84.92M 79.86M
Other stockholder equity 103.26M 103.50M 128.48M 134.41M 130.00M
Property plant equipment - - 44.89M 46.84M 42.84M
Total current assets 106.64M 97.99M 128.19M 131.12M 129.17M
Long term investments - - - - -
Net tangible assets - - 19.10M 9.41M 20.43M
Short term investments - - - - -
Net receivables 36.67M 9.49M 37.68M 45.70M 30.79M
Long term debt 35.26M 33.73M 0.23M 50.11M 53.09M
Inventory 42.75M 40.85M 58.26M 55.66M 59.29M
Accounts payable 25.99M 21.37M 47.36M 53.32M 42.90M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -6.88600M
Additional paid in capital - - - - -
Common stock total equity - - - - 1.38M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.07M 0.10M 0.14M 0.05M 0.06M
Deferred long term asset charges - - - - -
Non current assets total 113.60M 123.92M 164.49M 195.24M 181.28M
Capital lease obligations 15.63M 17.85M 24.19M 22.39M 20.27M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -2.51800M -6.18300M -4.18900M -15.66100M -104.40400M
Change to liabilities - - 2.53M 5.11M -0.15900M
Total cashflows from investing activities -2.51800M -6.18300M -4.18900M -15.66100M -104.40400M
Net borrowings 3.45M -4.61700M -2.72700M 2.13M 13.76M
Total cash from financing activities -0.42600M -8.83500M -4.39800M 1.70M 128.71M
Change to operating activities - - - - -
Net income -1.02300M 0.21M -9.48100M -9.13200M -11.16300M
Change in cash 3.89M -2.08300M -2.96000M 5.98M 23.53M
Begin period cash flow 20.07M 22.15M 29.76M 23.78M 6.50M
End period cash flow 23.96M 20.07M 26.80M 29.76M 30.03M
Total cash from operating activities 7.20M 12.66M 5.08M 20.02M -0.74800M
Issuance of capital stock - - 0.00000M 0.35M 115.76M
Depreciation 12.82M 13.04M 16.87M 18.45M 3.91M
Other cashflows from investing activities 0.26M 0.24M 0.13M 0.12M 0.04M
Dividends paid - - 1.57M 1.57M 1.57M
Change to inventory -1.87300M 7.31M -8.41800M 0.15M 0.65M
Change to account receivables -3.93100M -4.71100M 0.12M 1.92M 3.00M
Sale purchase of stock - - - - -
Other cashflows from financing activities -3.87700M -4.21800M 7.55M 24.22M 12.99M
Change to netincome - - 1.80M 3.27M -0.48400M
Capital expenditures 2.92M 5.75M 4.24M 7.64M 2.62M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2.05600M 0.07M -5.77200M 7.18M 3.49M
Stock based compensation 0.37M 0.97M 1.73M 1.48M 1.71M
Other non cash items -2.91000M 3.92M 1.73M 2.66M 1.84M
Free cash flow 4.28M 6.92M 0.84M 12.37M -3.36700M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
SPEC
Inspecs Group plc		 - -% 84.50 - 16.16 0.43 0.95 0.62 7.94
CTEC
ConvaTec Group PLC		 2.70 1.36% 201.40 37.27 14.66 1.79 3.77 2.94 13.89
AMS
Advanced Medical Solutions Group plc		 2.31 1.07% 218.81 40.60 16.84 1.92 1.66 2.16 11.16
TSTL
Tristel		 -2.4 0.63% 377.60 23.75 19.08 3.68 5.29 3.43 13.18
BVC
Batm Advanced Communications Ltd		 -0.4 2.99% 13.00 - 39.53 0.36 0.90 0.37 2.44

Reports Covered

Stock Research & News

View All

Profile

INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through Frames and Optics; Manufacturing; and Lenses segments. The company offers its products under the retail brands, such as Barbour, Barbour International, BUFFALO David Bitton, CAT, Free Country, Henri Lloyd, Hype, JOSEPH, Lamb, Liberty, Lyle & Scott, Marc O'Polo, MINI, O'Neill, SUPERDRY, RADLEY LONDON, TALBOT RUNHOF, Ted Baker, Temperley LONDON, and Victor Rolf; and in house brands under BOTANIQ, SAVILE ROW Titanium, SAVILE ROW, BRENDEL Eyewear, FREIGEIST, HUMPHREY'S eyewear, JOS ESCHENBACH, and TITANFLEX names. INSPECS Group plc was founded in 1988 and is based in Bath, the United Kingdom.

Inspecs Group plc

7-10 Kelso Place, Bath, United Kingdom, BA1 3AU

Key Executives

Name Title Year Born
Mr. Robin B.C. Totterman Founder & Exec. Chairman 1961
Mr. Richard D. Peck Group CEO & Non-Exec. Director 1965
Mr. Christopher D. Kay Group CFO & Director 1963
Martin Bates Sales Director NA
Mr. Steve Tulba Managing Director of Inspecs Division NA
Mr. Richard McGonigle Company Sec. NA
Mr. Richard Charles Peck Group CEO & Executive Director 1964
Mr. Robin Bjorn Christian Totterman Founder & Executive Director 1960
Mr. Christopher David Kay Chief Financial Officer 1963
Nick Youle Head of Innovations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions